Vitamin D is synthesised by ultraviolet (UV) irradiation of skin and is hypothesized to be a direct mediator of the immunosuppression that occurs following UV radiation (UVR) exposure. Both UVR and vitamin D drive immune responses towards tolerance by ultimately increasing the suppressive activities of regulatory T cells. To examine a role for UVR-induced vitamin D, vitamin D3-deficient mice were established by dietary vitamin D3 restriction. In comparison to vitamin D3-replete mice, vitamin D3-deficient mice had significantly reduced serum levels of 25-hydroxyvitamin D3 (25(OH)D3, <20 nmol.L−1) and 1,25-dihydroxyvitamin D3 (1,25(OH)2D3, <20 pmol.L−1). Following either acute erythemal UVR, or chronic sub-erythemal UVR (8 exposures over 4 weeks) treatment, serum 25(OH)D3 levels significantly increased in vitamin D3-deficient female but not male mice. To determine if UVR-induced vitamin D was a mediator of UVR-induced systemic immunosuppression, responses were measured in mice that were able (female) or unable (male) to increase systemic levels of 25(OH)D3 after UVR. Erythemal UVR (≥4 kJ/m2) suppressed contact hypersensitivity responses (T helper type-1 or -17), aspects of allergic airway disease (T helper type-2) and also the in vivo priming capacity of bone marrow-derived dendritic cells to a similar degree in female and male vitamin D3-deficient mice. Thus, in male mice, UVR-induced 25(OH)D3 is not essential for mediating the immunosuppressive effects of erythemal UVR.
Citation: Gorman S, Scott NM, Tan DHW, Weeden CE, Tuckey RC, Bisley JL, et al. (2012) Acute Erythemal Ultraviolet Radiation Causes Systemic Immunosuppression in the Absence of Increased 25-Hydroxyvitamin D3 Levels in Male Mice. PLoS ONE 7(9): e46006. doi:10.1371/journal.pone.0046006
Editor: Makoto Makishima, Nihon University School of Medicine, Japan
Received: May 21, 2012; Accepted: August 27, 2012; Published: September 26, 2012
Copyright: © Gorman et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was supported by grants from the National Health and Medical Research Council of Australia (#458612, PHH), the Cancer Council of Western Australia (#1008985, PHH and SG), the Asthma Foundation of Western Australia (SG and PHH), the Raine Foundation (SG and PHH), and the BrightSpark Foundation (SG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
UV irradiation of skin causes a systemic immunosuppression in both humans and mice . Much is still unknown about the mechanisms that control systemic immunity following UV irradiation . Postulated immune mediators of UV radiation (UVR)-regulated systemic immunosuppression include soluble products released by skin cells like keratinocytes and mast cells, altered antigen presenting cell precursors at distant sites like the bone marrow and UVR-induced regulatory T and B cells (reviewed in , ). A potential immune regulator induced by UVR is vitamin D3. For humans, much of our vitamin D3 is obtained from processes consequent to the absorption of UVB photons by 7-dehydrocholesterol in skin . The active form of vitamin D3, 1,25(OH)2vitamin D3 (1,25(OH)2D3), is then produced both locally by keratinocytes , and systemically by successive hydroxylations in the liver and kidney. Post-UV irradiation (or dietary intake), serum levels of the metabolite 25-hydroxyvitamin D3 (25(OH)D3) are used as a measure of vitamin D status.
In a recent review, we analysed whether vitamin D may be responsible for the immunosuppression that occurs after UVR . UV irradiation damages the DNA of skin-resident dendritic cells (DC) ,  and induces their migration into the skin-draining lymph nodes . These DCs then increase the suppressive activity and/or numbers of lymph node-resident CD4+CD25+Foxp3+ regulatory T cells –. Similarly, topical application of 1,25(OH)2D3 induces migration of skin DCs into the draining lymph nodes  to control regulatory T cells , . UVR  and topical calcipotriol (a vitamin D analog, ) both induce RANKL expression by keratinocytes, which in turn stimulate the expansion of antigen-specific regulatory T cells. These observations support a model of UVR-induced local immunosuppression (at the skin site that receives UVR) that is mediated through 1,25(OH)2D3 with downstream effects on keratinocytes, dendritic cells and regulatory T cells.
To date, investigations of UVR have not examined immune responses in vitamin D-deficient individuals. Indeed, the role of UVR-induced vitamin D in modulating immune-driven diseases has not (until the current study) been examined in vitamin D-deficient mice. Through dietary restriction, vitamin D deficiency enhanced the pathogenesis of immune-driven disorders such as diabetes , colitis  and arthritis  in rodent models. However, Becklund et al (2010), observed that UVR suppressed experimental autoimmune encephalomyelitis (EAE) in mice (a murine model of multiple sclerosis) when there were minimal changes in serum 25(OH)D3, suggesting that vitamin D3 may not be a central mediator of UVR-induced systemic immunosuppression .
In the current study, we used a novel approach to examine a role of UVR-induced vitamin D3 in suppressing systemic immune responses in murine models of contact hypersensitivity (CHS, T helper type-1/17 cell-mediated) and allergic airway disease (T helper type-2 cell-mediated). By provision of specially designed diets with or without vitamin D3, mice became vitamin D3-replete or -deficient, respectively. Mice were exposed to a single acute erythemal dose of UVR, or to chronic suberythemal UVR. After UV irradiation, significantly increased serum 25(OH)D3 levels were recorded only in female mice that were initially vitamin D3-deficient. Male vitamin D3-deficient mice consistently did not respond to UVR with no increases detected in serum 25(OH)D3 levels. We then evaluated immune responses in mice that were able (female) or unable (male) to synthesize vitamin D to evaluate a role for UVR-induced vitamin D in UVR-induced systemic immunosuppression.
Materials and Methods
Mice and Diet
All experiments were performed according to the ethical guidelines of the National Health and Medical Research Council of Australia and with approval from the Telethon Institute for Child Health Research Animal Ethics Committee. Mice were purchased from the Animal Resources Centre, Western Australia. Female 3 wk-old BALB/c mice were placed on semi-pure diets which were (SF05-34, Specialty Feeds, Perth, Western Australia, 1% Ca2+) or were not (SF05-033, Specialty Feeds, 2% Ca2+) supplemented with 2280 IU vitamin D3/kg. At 8 weeks of age, female mice were mated with adult male BALB/c mice maintained on standard mouse chow (Specialty Feeds). Offspring born following these matings were maintained on the vitamin D3-replete or -deficient diets for the rest of the experiment. In some experiments BALB/c or C57Bl/6 mice were placed on the vitamin D3-replete or -deficient diets from 4 weeks of age. Mice were housed under perspex-filtered fluorescent lighting, which emitted no detectable UVB radiation as measured using a UV radiometer (UVX Digital Radiometer, Ultraviolet Products Inc., Upland, CA, USA).
Measurement of Serum Vitamin D and Calcium Levels
Levels of 25(OH)D3 and 1,25(OH)2D3 levels were measured in serum and/or ear tissue lysates  using IDS EIA ELISA kits (Immunodiagnostic Systems Ltd, Fountain Hills, AZ) as described by the manufacturer. Ear lysates were prepared as previously described by Biggs et al (2010) for quantification of 1,25(OH)2D3 levels 24 h after skin exposure to UVR . 1,25(OH)2D3 levels were adjusted to account for the diluting effects of edema which occurs 24 h after exposure of skin to erythemal UVR. For confirmation, 25(OH)D3 levels in selected samples were measured using the DiaSorin Liaison method (Saluggia, Italy) and by isotope-dilution liquid chromatography-tandem mass spectrometry by RMIT Drug Discovery Technologies (Melbourne, Australia). Calcium levels in serum were determined by the Vitros dry chemistry method (Vitros 250, Ortho Clinical Diagnostics, Raritan, NJ).
A bank of six 40 W lamps (Philips TL UV-B, Eindhoven, The Netherlands) emitting broadband UVR, 250–360 nm, with 65% of the output in the UVB range (280–315 nm), was used to irradiate mice to deliver various doses of UVR onto clean-shaven 8 cm2 dorsal skin as previously described , . A new sheet of PVC plastic film (0.22 mm) was taped to the top of each perspex cage immediately before irradiation to screen wavelengths <280 nm. Sunlamps were held 20 cm above the cages. Unless used in CHS experiments, the ears were not covered or taped for the UV treatments.
Measurement of 7-dehydrocholesterol Levels in Skin
Shaved dorsal skin (1 cm2) was removed from mice and snap-frozen in liquid N2. 7-dehydrocholesterol was extracted from 0.1 g of the frozen skin by homogenization with 4 ml CHCl3/CH3OH 1∶1 (v/v) as described for cholesterol extraction . 7-dehydrocholesteol esters present in the extract were hydrolysed with sodium methoxide and then quantitated by HPLC as previously described , except that a C18 column (Kinetex 5 cm × 4.6 mm particle size 2.6 µm) was used with samples being applied in 80% methanol and eluted with a 80–100% methanol gradient in water (25 min) followed by 100% methanol (15 min) at a flow rate of 0.5 ml/min. 7-dehydrocholesterol was detected with a UV monitor at 280 nm.
Detection of mRNA
Messenger mRNA was extracted from the kidneys of naïve 8 week-old vitamin D3-replete or -deficient mice with cDNA synthesized and real-time assays performed as previously described ,  using Quantitect Primer Assays (Qiagen, Doncaster, VIC, Australia) for detection of CYP27B1 and CYP24A1 with EEF1α used as the house-keeping control .
A CHS assay was performed using 2,4-dinitrofluorobenzene (DNFB, Sigma Chemical Company, St Louis, MO) as previously described , . Mice were sensitized by painting 25 µl 0.5% DNFB diluted in acetone onto the shaved ventral surface. After another 5 days, a CHS response was elicited by painting dorsal and ventral ear surfaces with 10 µl 0.2% DNFB (in acetone). After 24 hours, the ear thickness was measured in a blinded manner spring-loaded micrometer (Mitutoyo Corp, Aurora, IL) as described previously . In all experiments, some mice were challenged but not sensitized with 0.2% DNFB (in acetone).
Measurement of Edema in UV-irradiated Skin
At various times post-UV irradiation, the double skin thickness of back skin was measured using a spring-loaded micrometer at 3 locations, 1 cm apart, across the back. These measurements were averaged and the pre-UV irradiation reading subtracted.
Measuring the in vivo Priming Capacity of Bone Marrow-derived DCs (BMDCs)
DCs were expanded in vitro from the bone marrow of mice harvested 3 days after UV irradiation. CD11c+ cells were purified from the loosely adherent bone marrow cells resulting after 7 days culture with GM-CSF and IL-4 as previously described . The cells were loaded with dinitrobenzenesulfonic acid-sodium salt prior to subcutaneous injection of 106 cells into the ear pinnae of naïve (vitamin D3-replete) mice. Dinitrobenzenesulfonic acid-sodium salt is a water-soluble analogue of DNFB. Cells were obtained from and injected into mice of the same sex. Seven days later, each ear pinnae of the recipient mice was challenged with 10 µl DNFB (0.2% in acetone), and ear-swelling responses measured 24 h after this challenge using a spring-loaded micrometer.
Bronchoalveolar Lung Lavage of Mice Sensitized and Challenged with Ovalbumin
OVA (Sigma) in alum (Serva, Heidelberg, Germany) was delivered i.p. on day 0 (10 µg OVA in 2 mg alum per mouse; 200 µl volume) and again on day 14. Mice were then challenged on days 21, 22 and 23 with a 1% OVA-in-saline aerosol delivered using an ultrasonic nebulizer (UltraNebs, DeVilbiss, Somerset, PA) for 30 min . Twenty-four hours after the final aerosol, BALF was collected as described previously . BALF cells were then centrifuged onto slides and stained using the DIFF-Quik Stain Set 64851 (Lab Aids, Narrabeen, NSW, Australia) as per the manufacturer’s instructions. Levels of IL-5 in BALF were detected using ELISA as previously described .
Generating Vitamin D3-replete and -deficient Mice
Dietary manipulation was used to generate vitamin D3-deficient and -replete mice . BALB/c female mice were fed vitamin D3-containing (replete) or -null diets from 3 weeks of age. Upon weaning offspring born to these female mice were continued on the restricted diet of their mother. At 8 weeks of age (adulthood), the offspring mice raised on the diets that were or were not supplemented with vitamin D3 were of equal weight and size, and had mean serum levels of 25(OH)D3 of >50 nmol.L−1 and <20 nmol.L−1, respectively (Figure 1A) . As observed previously, male mice fed the vitamin D3-replete diet had significantly lower serum levels of 25(OH)D3 than female mice fed the same diet (Figure 1A) . Levels of the further hydroxylated form, 1,25(OH)2D3 were significantly lower in the serum of vitamin D3-“deficient” mice compared with -“replete” mice as observed previously , although there was no difference in levels observed between female and male mice (Figure 1B). There was no difference in the serum calcium levels recorded for mice on either diet (Figure 1C).
Female BALB/c mice were placed on vitamin D3 (VitD)-containing or -deficient diets from 3 weeks of age. At 8 weeks of age the female mice were mated with adult BALB/c male mice (fed vitamin D3-replete diets). In (A), (B) and (C), serum 25(OH)D3, 1,25(OH)2D3 and calcium levels (respectively) were measured in female and male 8 week-old offspring of these matings (n = 5 mice/group). In (D), 7-dehydrocholesterol levels were determined in the skin of vitamin D3-deficient female and male mice. In (E), kidney CYP27B1 mRNA levels induced by vitamin D3 deficiency in female and male mice are shown. In (F), kidney CYP27B1 and CYP24A1 mRNA levels induced by being male for vitamin D3-replete (VitD+) and -deficient (VitD-) mice. For (A)–(F), data is shown as mean + SEM, with n≥3 mice/group, *p<0.05 between groups, #p<0.05 relative to levels in vitamin D3-replete (E) or female (F,G) mice.
Male Vitamin D3-deficient Mice have Reduced Skin Levels of the Vitamin D Precursor, 7-dehydrocholesterol
Levels of the vitamin D3 precursor, 7-dehydrocholesterol, were significantly lower in the skins of vitamin D3-deficient male than female mice when mice were tested at 8 weeks of age (Figure 1D). In the kidneys, vitamin D3 deficiency per se enhanced CYP27B1 mRNA levels above levels observed in vitamin D3- replete animals for both female and male mice (Figure 1E). CYP27B1 is the 25-hydroxyvitamin D3 1α-hydroxylase that hydroxylates 25(OH)D3 to form 1,25(OH)2D3 , . Male vitamin D3-replete and -deficient mice also expressed increased levels of CYP27B1 mRNA than female vitamin D3-replete and -deficient mice, respectively (Figure 1F). Male vitamin D3-deficient mice expressed 3-fold more CYP24A1 mRNA in the kidneys than female -deficient mice (Figure 1F), but this was not observed in the vitamin D3-replete mice. CYP24A1 encodes an enzyme responsible for initiating degradation of 1,25(OH)2D3 , .
Vitamin D Status in Male Vitamin D3-deficient Mice is Unaltered by UVR
Serum levels of 25(OH)D3 in vitamin D3-replete mice did not significantly change from those depicted in Figure 1A in response to acute erythemal (8 kJ/m2) or chronic sub-erythemal UV irradiation (8 exposures to ≤2 kJ/m2 UVR over 4 weeks)(data not shown). However, in vitamin D3-deficient mice, significant increases in serum 25(OH)D3 levels were measured in the female but not the male mice in response to a single dose of 4 or 8 kJ/m2 UVR (Figure 2A). In female vitamin D3-deficient mice a significant increase was detected in response to a single exposure of 2 kJ/m2 UVR but not 1 kJ/m2 UVR, 4 and 11 days after irradiation (Figure 2B), although serum levels remained <25 nmol.L−1. In response to chronic low dose UVR (1 or 2 kJ/m2) administered 8 times over 4 weeks, serum 25(OH)D3 levels increased in female but not male vitamin D3-deficient mice (Figure 2C). When 8-week old female and male vitamin D3-deficient mice were fed the vitamin D3-supplemented diet for 4 weeks, all mice increased their serum 25(OH)D3 levels to >50 nmol.L−1 (Figure 2D). As observed previously (Figure 1A) , male mice fed the vitamin D3-supplemented diet had significantly lower serum 25(OH)D3 in comparison to female mice (Figure 2D). These levels were comparable to those observed in mice fed the vitamin D3-supplemented diet from conception until adulthood (Figure 1A) . In comparison to 4 week-old (post-weaning, pre-pubescent) female mice, 4 week-old male mice also failed to produce significant serum 25(OH)D3, 7 days after irradiation with 4 kJ/m2 UVR (Figure 2E). Serum calcium levels of female and male vitamin D3-deficient mice did not change when measured 7 days after 8 kJ/m2 UVR (Figure 2F). Vitamin D3-replete 4-week old BALB/c (Figure 2G) or C57Bl/6 (Figure 2H) mice were fed a vitamin D3-deficient diet for 28 days prior to UV irradiation (8 kJ/m2). Only the female mice responded to UV exposure with significantly increased serum 25(OH)D3 levels, 7 days post-UVR. Thus, the inability of male mice to alter the serum 25(OH)D3 levels after UVR was not dependent on whether they had been maintained on a vitamin D3-containing diet since conception.
The shaved dorsal surfaces of eight week-old female and male offspring of vitamin D3-deficient female BALB/c mice were irradiated with either (A) a single dose of 4 or 8 kJ/m2 UV (n ≥4 mice/group, *p<0.05 for female versus male), or (B) females were irradiated with 1 or 2 kJ/m2 UV (*p<0.05 for 1 versus 2 kJ/m2 UV). After 1, 4, 7 and/or 11 days, serum 25(OH)D3 levels were measured. In (C), vitamin D3-deficient offspring were chronically irradiated with 1 or 2 kJ/m2 UV at the times indicated by arrows and serum 25(OH)D3 levels monitored (n = 3 mice/group, *p<0.05 for female versus male). In (D), vitamin D3-deficient offspring were placed on the vitamin D3-replete diet and serum 25(OH)D3 levels assessed over 30 days (n = 8 mice/group, *p<0.05 for all times versus 0 days). In (E), 4 week-old vitamin D3-deficient mice were irradiated with 4 kJ/m2 UV, with serum 25(OH)D3 levels measured 7 days post-irradiation (n = 3 mice/group, *p<0.05). In (F), serum calcium levels were determined in female and male vitamin D3-deficient mice 7 days after 8 kJ/m2 UV irradiation (n = 6 mice/group). In (G) and (H), 4 week-old vitamin D3-replete BALB/c or C57Bl/6 mice were fed a vitamin D3-deficient diet for 28 days before UV irradiation (8 kJ/m2), respectively. After a further 7 days, serum 25(OH)D3 levels were measured (n = 5 mice/group, *p<0.05 for female versus male). For (A)–(D), (G) and (H), data are shown as mean ± SEM, and for (E) and (F), data are shown as mean + SEM.
1,25(OH)2D3 Levels Increase in the Skin of Vitamin D3-replete Females but not Males 24 h after Acute Erythemal UVR
Keratinocytes express the full repertoire of enzymatic machinery required for the conversion of 7-dehydrocholesterol into active 1,25(OH)2D3 following UV irradiation of skin . Vitamin D3-replete or -deficient BALB/c mice were exposed to 8 kJ/m2 and the levels of 1,25(OH)2D3 assessed 24 h later in UV-irradiated ear skin. Increased 1,25(OH)2D3 levels were observed in ear skin lysates of vitamin D3-replete female, but not male mice (Figure 3A). In addition, no change in 1,25(OH)2D3 levels was detected in the ear skin of either male or female vitamin D3-deficient mice with UV irradiation (Figure 3A). UVR (8 kJ/m2) also did not significantly alter serum 1,25(OH)2D3 levels at 4 days post-irradiation (Figure 3B), which remained significantly reduced in the serum of the vitamin D3-deficient mice relative to the -replete controls (Figure 3B).
Levels of 1,25(OH)2D3 were assessed in the (A) skin and (B) serum of vitamin D3-replete (VitD) or -deficient female or male BALB/c mice exposed to 0 or 8 kJ/m2 UVR. In (A), 1,25(OH)2D3 were assessed in the ear skin of mice (n = 6 ears/treatment) 24 h after UVR. In (B), 1,25(OH)2D3 were assessed in the serum of mice (n≥4 mice/treatment) 96 h after UVR. For (A) and (B), data is shown as mean + SEM, *p<0.05 between groups.
Can UVR Suppress CHS Responses in Vitamin D3-deficient Mice when Antigen is Applied to a Skin Site Distant to that UV-irradiated?
A CHS assay provides a measure of a T helper type-1/17-driven immune response and has been frequently used to study UVR-induced immune suppression in both humans and mice , . The “systemic” immunosuppressive effects of UVR were examined in vitamin D3-deficient female and male BALB/c mice by delivering UVR to the shaved dorsal skin of mice 4 days before the exposure of ventral skin to the sensitizer, DNFB. In separate experiments, 4 or 8 kJ/m2 UVR significantly suppressed the CHS response in both the female and male vitamin D3-deficient mice to a similar degree (Figure 4A). To evaluate the extent of the UVR insult, vitamin D3-deficient and -replete mice were administered different doses of UVR and the induced edema measured. Both UVR doses were edemal, but importantly the edema was not altered by vitamin D3 deficiency (Figure 4B for results in male mice, data not shown for female mice). As observed previously –, , UVR (≥4 kJ/m2) suppressed systemic CHS ear-swelling responses in female or male vitamin D3-replete mice by ∼50% (data not shown). We observed no difference in the CHS responses in the vitamin D3-replete or -deficient mice (data not shown). In addition, UV-induced lymph node hypertrophy ,  was measured in the auricular lymph nodes (ALN) of vitamin D3-deficient mice irradiated with 0 or 8 kJ/m2 UV (Figure 4C). The number of ALN cells per mouse was increased by a similar extent in both female and male mice, 4 days post-UV irradiation. In summary, UVR suppressed CHS responses in vitamin D3-deficient males in a systemic fashion when antigen was applied to a non-irradiated site, and enhanced skin edema and LN hypertrophy, in the absence of changes to circulating 25(OH)D3 levels (Figure 2).
Results shown were combined from four experiments in which the shaved dorsal skins of mice were irradiated with 4 (2 experiments) or 8 kJ/m2 UV (2 experiments). Mice were sensitized through the ventral skin with DNFB, 4 days after UV irradiation, and ears challenged 4 days later with ear swelling measured after a further 24 h. In (A), results from female and male mice are depicted as open and closed bars, respectively. In (B), the double skin-fold thickness of dorsal skin of vitamin D3-replete (solid lines) and vitamin D3-deficient (broken lines) male mice after irradiation with 4 or 8 kJ/m2 UV irradiation is shown at various times for a representative experiment (of 3 performed). In (C), the number of ALN cells per mouse is shown 4 days after irradiation of (unprotected) ears with 4 kJ/m2 UV. For (A) and (C), results are shown as mean + SEM and data in (B) is shown as mean ± SEM (*p<0.05, n = 4 mice/treatment/experiment).
Can UVR Suppress CHS Responses in Vitamin D3-deficient Mice when Antigen is Applied to the UV-irradiated Site?
The immunosuppressive effects of UVR were also examined locally by delivering UVR (8 kJ/m2) to the shaved dorsal skin of vitamin D3-deficient mice, 4 days before application of DNFB to the same dorsal skin site. UVR significantly suppressed “local” CHS responses in both the female and male vitamin D3-deficient mice to a similar extent (Figure 5A).
(A) CHS responses when antigen was applied to the UV-irradiated site. Ear thickness after the sensitization and challenge of BALB/c mice with DNFB is shown. Shaved dorsal skins of mice were irradiated with 8 kJ/m2 UV. Mice were sensitized through the dorsal skin with DNFB (4 days after UV irradiation) and ears challenged 4 days later with ear swelling measured after a further 24 h. (B) BMDCs from UV-irradiated female or male vitamin D3-deficient mice have impaired in vivo priming abilities. Female and male vitamin D3-deficient BALB/c mice were irradiated with 8 kJ/m2 UVR. Three days later, DCs were expanded by culturing bone marrow cells from the non-irradiated and UV-irradiated mice for 7 days with GM-CSF and IL-4. Isolated CD11c+ cells were loaded with dinitrobenzenesulfonic acid-sodium salt and then injected epicutaneously into the ears of naïve mice. After a further 7 days, the ears of recipient mice were challenged with DNFB and ear swelling measured 24 h later. For both (A) and (B), ear thickness measurements are shown as mean + SEM (*p<0.05, n = 4 mice/treatment), with results from female and male mice depicted as open and closed bars, respectively.
UVR Reduces the in vivo Priming Ability of Bone Marrow-derived DCs from Vitamin D3-deficient Female and Male Mice to a Similar Extent
BMDCs from UV-irradiated mice have an impaired ability to prime immune responses in vivo . To examine the systemic effect of UVR in vitamin D3-deficient mice, DCs were expanded in vitro from the bone marrow of UV-irradiated mice and used to prime a CHS response in naïve (and sex-matched) mice. UVR significantly suppressed the capacity of BMDCs (CD11c+ cells) from female and male vitamin D3-deficient mice to prime T helper type-1/17 ear-swelling responses in recipient mice to a similar extent (Figure 5B). These results suggest that the capacity of UVR to modify DC precursors in the bone marrow is independent of circulating levels of 25(OH)D3 post-UV irradiation.
‘Low’ Dose UVR Significantly Increases Serum 25(OH)D3 Levels without Suppressing Local Immune Responses
To further differentiate the outcomes of UVR and increased serum 25(OH)D3 levels, three daily doses of 2 kJ/m2 UVR  were administered to the dorsal skin of female vitamin D3-deficient BALB/c mice before applying DNFB to dorsal skin 24 h after the final UV irradiation (Figure 6A). Multiple 2 kJ/m2 doses of UVR raised serum 25(OH)D3 levels to >50 nmol.L−1 in female mice (Figure 6A). This UVR regime did not suppress ear-swelling responses in the irradiated BALB/c mice (Figure 6B) to a ‘locally’-applied antigen (DNFB), even though mice were sensitized when serum levels of 25(OH)D3 had significantly increased post-UVR (Figure 6A). These observations again confirm that the ability of UVR to modulate serum 25(OH)D3 is independent of its capacity to suppress immune responses in the strains of mice tested.
The shaved dorsal skin of female vitamin D3-deficient BALB/c mice was irradiated (or not) with three daily doses of 2 kJ/m2 UVR (+ UV). Mice were sensitized through the dorsal skin with DNFB (4 days after UV irradiation) and ears challenged 4 days later. Ear swelling measured after a further 24 h. In (A), serum 25(OH)D3 levels were determined 24 h after the final UV irradiation, and 24 h after ear-challenge. In (B), ear thickness measurements are shown. Data is shown in (A) as mean ± SEM and in (B) as mean + SEM (n = 4 mice/treatment, *p<0.05 for + UV versus − UV).
Effect of UVR on Allergic Airway Responses in Vitamin D3-deficient Mice
We have previously shown that erythemal UV irradiation (≥2 kJ/m2) of skin reduces asthma-like pathologies in two murine models of allergic airways disease , . To determine the contribution of vitamin D3 towards regulating allergic airway disease after UV irradiation, vitamin D3-deficient female or male mice were UV-irradiated (8 kJ/m2), or not, 3 days before sensitization with ovalbumin (OVA) with the adjuvant, alum. The extent of allergic airways disease was examined 24 h after the final respiratory challenge with OVA. In each of three independent experiments, sensitization to OVA was greater in the female than male vitamin D3-deficient mice (Figure 7). This was shown in the non-irradiated mice, where more eosinophils (Figure 7A) and increased IL-5 levels (Figure 7B) were detected in the BALF of the female mice. For results combined from three experiments, the number of eosinophils (Figure 7A) and the levels of IL-5 (Figure 7B) in the BALF were significantly reduced by UV irradiation of the female and male mice that were initially vitamin D3-deficient. After normalization to remove the variation in sensitization observed between the female and male mice, there was no difference in the extent of UVR-induced suppression of eosinophil numbers (Figure 7C) or IL-5 concentrations (Figure 7D) in the BALF observed in the female and male mice. Thus, in the absence of UVR-induced increases in serum 25(OH)D3 in the male vitamin D3-deficient mice, UVR significantly suppressed T helper type-2-specific responses (eosinophilia and IL-5 in lavage fluid) in this model of allergic airway disease.
Vitamin D3-deficient female or male BALB/c mice were UV irradiated (8 kJ/m2) and three days later were sensitized and boosted with OVA and alum on days 0 and 14, respectively. On days 21, 22 and 23 mice were challenged with an OVA aerosol. After a further 24 h, bronchoalveolar lavage fluid was obtained. In (A), eosinophil numbers, and in (B), IL-5 concentrations in the bronchoalveolar lavage fluid are shown. In (C) and (D), eosinophil numbers and IL-5 concentrations were normalized relative to eosinophils numbers and IL-5 concentrations measured for non-irradiated OVA-sensitized, -boosted and -challenged mice to remove the effects of gender on allergic sensitization. The mean result from each experiment was used to calculate the results shown (mean + SEM, n = 3 experiments, *p<0.05, n = 4 mice/group/experiment), with results from female and male mice depicted as open and closed bars, respectively.
In this study, male vitamin D3-deficient mice were unable to increase their serum 25(OH)D3 levels in response to UVR, in contrast to female mice. Even though serum 25(OH)D3 levels did not change after UV treatment of male mice, the capacity of a single erythemal dose of UVR to suppress immune responses was very similar in male and female vitamin D3-deficient mice. Multiple immune models (CHS and allergic airway disease) were used to show that UVR-induced immunosuppression was independent of serum levels of 25(OH)D3. A variety of substances produced by skin cells aside from vitamin D3 may control UVR-induced systemic immunosuppression , . For example, UV irradiation of skin acts at least partially through prostanoids to reduce the immune priming ability of BMDCs . Furthermore, after erythemal UVR, prostaglandin E2 signals through the EP4 receptor to increase regulatory T cell numbers through enhanced epidermal RANKL expression . While further work is required to characterize the immune pathways responsible for the systemic immunosuppression caused by UVR, we now present evidence that UVR-induced vitamin D may not be essential for immunosuppression.
UVR did not increase serum 25(OH)D3 levels in either BALB/c or C57Bl/6 vitamin D3-deficient male mice, suggesting that this effect is not strain-dependent. This defect is not detrimental to the general health of male mice as while they are mainly nocturnal and covered in fur, and they have evolved an efficient system to obtain vitamin D3 from their food and not skin exposure to sunshine. Our studies and those of others , suggest that synthesis of vitamin D3 by UVR in the skin of vitamin D3-deficient mice occurs by the same processes in mice as for humans. We propose that reduced levels of the precursor 7-dehydrocholesterol in the skin of male versus female mice (summarized in Figure 8) contributes significantly towards the inability of male mice to produce serum 25(OH)D3 after UV irradiation but are uncertain as to why male mice have less 7-dehydrocholesterol than females. Other mammals exhibit very low or undetectable quantities of 7-dehydrocholesterol in their skin, including cats and dogs . In humans, the extent of variation of cutaneous 7-dehydrocholesterol levels is not known. In patients with dietary malabsorption disorders like Crohn’s disease, 7-dehydrocholesterol levels are increased in their skin relative to age- and sex-matched control subjects . This interesting finding does indicate that there may be regulatory links between vitamin D metabolism in the skin and gut, but these need further investigation. Age reduces 7-dehydrocholesterol levels in human skin . As UVR did not increase 25(OH)D3 levels in 4 week-old pre-pubescent male mice, their modulation by UVR in female mice only is likely to be independent of hormonal status.
Other non-skin-related defects in vitamin D metabolism exist in male mice as serum levels of 25(OH)D3 were lower in male mice fed a vitamin D3-replete diet relative to the female animals. In addition, the expression of the 1,25(OH)2D3 synthesis and breakdown enzymes (CYP27B1 and CYP24A1, respectively) in the kidneys were upregulated in male, relative to female vitamin D3-deficient mice suggesting that 1,25(OH)2D3 metabolism and catabolism may occur at a faster rate in male mice, as suggested by others . Even so, male and female vitamin D3-deficient mice had similarly reduced serum levels of 1,25(OH)2D3, relative to their -replete counterparts, as observed previously . The extent of ear swelling induced by a CHS assay was comparable in male and female mice using the hapten dinitrofluorobenzene (eg. Figure 4A). Others have also reported that the capacity of UVB irradiation to modulate CHS responses is equivalent in male and female (vitamin D-replete) mice ,  but describe gender differences in UV-induced inflammation and immunosuppression in response to exposure to UVA radiation (315–400 nm) . It is the UVB wavelengths of sunlight that are responsible for converting 7-dehydrocholesterol into pre-vitamin D in the skin , and are of most relevance for the current studies.
A summary of the synthesis of 1,25(OH)2D3 from 7-dehydrocholesterol in skin in relation to the observed effects on this pathway following UV-irradiation of vitamin D3-deficient female and male mice. Post-UVR changes in 25(OH)D3 and 1,25(OH)2D3 levels are depicted by arrows with no change shown as (−).
In the vitamin D3-deficient mice, we did not observe significant synthesis of 1,25(OH)2D3 in skin 24 h after exposure to erythemal UVR, which suppressed both systemic and local CHS responses in the vitamin D3-deficient mice. These results suggest that the ability of erythemal UVR to suppress immunity may be independent of cutaneous synthesis of 1,25(OH)2D3. However, a role for 1,25(OH)2D3 in modulating immunity after chronic sub-erythemal UVR is plausible. Indeed, local skin inflammation induced by chronic sub-erythemal UVR may be controlled by mast cells and their response to UVR-induced 1,25(OH)2D3 . Inflammation induced by chronic UVR (2 kJ/m2, 15 doses over 30 days) was enhanced in the skin of mast cell-deficient mice (WBB6F1-KitW/Wv) that were engrafted with bone marrow-derived mast cells from VDR−/− mice relative to wild-type controls . These studies suggest that the VDR may be important for the ability of mast cells to suppress skin inflammation caused by sub-erythemal UVR. It is therefore possible that 1,25(OH)2D3 may be an important mediator that controls local skin immune responses after chronic sub-erythemal but not erythemal doses of UVR. In addition, many different immune cells, including dendritic cells can synthesize 1,25(OH)2D3 to potentially modulate local immunity . However, we anticipate that low levels of circulating 25(OH)D3 may reduce the capacity of such cells to synthesize 1,25(OH)2D3 to regulate immunity, especially in male mice, where UVR alone cannot modify serum 25(OH)D3 levels.
UV irradiation of skin can be beneficial in the treatment of not only hypersensitivity responses and models of asthma, but also models of multiple sclerosis , and by inference other diseases characterized by hyperimmune reactivity. This study complements an examination of UV control of EAE in mice . UV irradiation of skin reduced the expression of the disease but as the mice used were not vitamin D3-deficient, there were minimal measurable changes in serum 25(OH)D3 levels. As previously published , the EAE disease model can be regulated by a diet containing 1,25(OH)2D3, and to a lesser extent by a diet containing very high levels of 25(OH)D3. The diet containing the 1,25(OH)2D3 stimulated significant hypercalcaemia which, rather than the vitamin D3 per se, may regulate EAE development . In contrast, UVR reduced EAE symptoms in mice but calcium levels did not change .
In this study, we have used a physiological model of vitamin D3-deficiency and not VDR or CYP27B1 knockout mice to investigate a role for vitamin D in mediating UV-induced immunosuppression. There are many problems associated with using mice with the VDR or CYP27B1 gene knocked out globally, or even in a tissue-specific manner. Both VDR−/− and CYP27B1−/− mice have serious developmental problems that lead to dermatological, skeletal, reproductive and immune dysfunction . For adequate bone development and survival, VDR−/− knockout mice need to be fed a rescue diet consisting of 2% Calcium and 20% Lactose . VDR−/− mice also have alopecia and exhibit keratinocyte stem cell defects . CYP27B1−/− mice do not have alopecia, but their keratinocytes exhibit reduced expression of differentiation markers and have an inhibited ability to recover normal skin barrier function after an acute perturbation . The alopecia observed in the VDR−/− mice is independent of 1,25(OH)2D3 expression. We anticipate that these ligand-independent effects would still occur in the skin of mice with keratinocyte-specific knockdown of expression of the VDR. Other studies indicate that the VDR acts as a tumour suppressor independently of 1,25(OH)2D3. VDR−/− mice exhibit reduced rates of thymine-dimer repair and apoptosis in UV-exposed skin and these dysfunctional epidermal repair pathways coincided with an enhanced susceptibility to the development of skin tumours induced by chronic UV irradiation or by a chemical carcinogen . In a recent paper, normal bone phenotype in CYP27B1−/− mice was partially restored by treating the knockout mice with vitamin D3 . In particular, body weight and bone-related parameters were restored by chronic intramuscular treatment with 10,000 IU vitamin D3/week for 4 weeks . These effects were mediated in the absence of conversion to 1,25(OH)2D3, where 25(OH)D3 may be another albeit lower-affinity ligand of the VDR. These studies suggest that CYP27B1−/− mice can still respond to vitamin D, and are thus an incomplete model to study the effects of ‘vitamin D deficiency’ on disease. Finally, results observed in vitamin D3-deficient mice are not always found in VDR−/− mice. For example, a reduced asthma phenotype occurs in VDR−/− mice  while asthma severity is enhanced in vitamin D3-deficient mice  and inhibited in mice treated with 1,25(OH)2D3 –. Together, these findings using VDR−/− and CYP27B1−/− mice further highlight how the development and regeneration of the skin (and other tissues) of these knockout mice is dependent on the expression of the VDR (and perhaps also CYP27B1), and indicate that they are not suitable (or physiologically relevant) models for investigating the effects of UVR on skin immunity.
Our physiologically-relevant studies show that male vitamin D3-deficient mice are unable to make 25(OH)D3 in response to UVR when deficiency was induced only by removal of vitamin D3 from the diet. The levels of 25(OH)D3 observed in the mice on the vitamin D3-null diet mimic the cut-offs for vitamin D deficiency (<25 nmol.L−1) suggested for humans . The source of vitamin D3 for these deficient mice with low, but detectable serum 25(OH)D3 levels is unknown, but may be due to a naturally-occurring contaminant of the wheat starch component of the non-vitamin D3-supplemented diet. Our findings have significant health implications. We demonstrate that the potential benefits of UVR in reducing the morbidity associated with systemic immune disorders such as asthma or multiple sclerosis, may not be dependent on circulating levels of 25(OH)D3, as particularly observed in male mice. Based on the experimental models tested, we observed that vitamin D synthesis is not required for systemic (or local) immunosuppression after erythemal UVR. In conclusion, this study suggests that while the benefits of UV irradiation of skin and vitamin D3 supplementation in modulating inappropriate systemic immune responses may be complementary, vitamin D synthesis is not essential for mediating the immunosuppressive effects of UVR.
We thank Professor Greg Woods and Dr Roslyn Malley from the University of Tasmania for their advice in establishing the vitamin D3-replete and -deficient mouse colonies. We also thank Associate Professor Scott Wilson of the School of Medicine and Pharmacology Department at the University of Western Australia for loan of his gas distribution manifold.
Conceived and designed the experiments: SG DHWT MAG PHH. Performed the experiments: SG NMS DHWT CEW RCT JLB PHH. Analyzed the data: SG NMS DHWT CEW RCT MAG PHH. Wrote the paper: SG PHH.
- 1. Kelly DA, Young AR, McGregor JM, Seed PT, Potten CS, et al. (2000) Sensitivity to sunburn is associated with susceptibility to ultraviolet radiation-induced suppression of cutaneous cell-mediated immunity. J Exp Med 191: 561–566.
- 2. Halliday GM (2010) Common links among the pathways leading to UV-induced immunosuppression. J Invest Dermatol 130: 1209–1212.
- 3. Hart PH, Gorman S, Finlay-Jones JJ (2011) Modulation of the immune system by UV radiation: more than just the effects of vitamin D? Nat Rev Immunol 11: 584–596.
- 4. Norval M, Halliday GM (2011) The consequences of UV-induced immunosuppression for human health. Photochem Photobiol 87: 965–977.
- 5. Bouillon R, Carmeliet G, Verlinden L, van Etten E, Verstuyf A, et al. (2008) Vitamin D and human health: Lessons from vitamin D receptor null mice. Endocr Rev 29: 726–776.
- 6. Lehmann B, Sauter W, Knuschke P, Dressler S, Meurer M (2003) Demonstration of UVB-induced synthesis of 1α,25-dihydroxyvitamin D3 (calcitriol) in human skin by microdialysis. Arch Dermatol Res 2003 295: 24–28.
- 7. Vink AA, Moodycliffe AM, Shreedhar V, Ullrich SE, Roza L, et al. (1997) The inhibition of antigen-presenting activity of dendritic cells resulting from UV irradiation of murine skin is restored by in vitro photorepair of cyclobutane pyrimidine dimmers. Proc Natl Acad Sci U S A 94: 5255–5260.
- 8. Schwarz A, Maeda A, Kernebeck K, van Steeg H, Beissert S, et al. (2005) Prevention of UV radiation-induced immunosuppression by IL-12 is dependent on DNA repair. J Exp Med 201: 173–179.
- 9. Ghoreishi M, Dutz JP (2006) Tolerance induction by transcutaneous immunization through ultraviolet-irradiated skin is transferable through CD4+CD25+ T regulatory cells and is dependent on host-derived IL-10. J Immunol 176: 2635–2644.
- 10. Gorman S, Kuritzky LA, Judge MA, Dixon KM, McGlade JP, et al. (2007) Topically applied 1,25-dihydroxyvitamin D3 enhances the suppressive activity of CD4+CD25+ cells in the draining lymph nodes. J Immunol 179: 6273–6283.
- 11. Ghoreishi M, Bach P, Obst J, Fleet JC, Dutz JP (2009) Expansion of antigen-specific regulatory T cells with the topical vitamin D analog calcipotriol. J Immunol 182: 6071–6078.
- 12. Gorman S, Judge MA, Hart PH (2010) Topical 1,25-dihydroxyvitamin D3 subverts the priming ability of draining lymph node dendritic cells. Immunology 131: 415–425.
- 13. Loser K, Mehling A, Loeser S, Apelt J, Kuhn A, et al. (2006) Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells. Nat Med 12: 1372–1379.
- 14. Giulietti A, Gysemans C, Stoffels K, van Etten E, Decallonne B, et al. (2004) Vitamin D deficiency in early life accelerates Type 1 diabetes in non-obese diabetic mice. Diabetologica 47: 451–462.
- 15. Lagishetty V, Misharin AV, Liu NQ, Lisse TS, Chun RF, et al. (2010) Vitamin D deficiency in mice impairs colonic antibacterial activity and predisposes to colitis. Endocrinology 151: 2423–2432.
- 16. Moghaddami M, Mayrhofer G, Anderson PH, Morris HA, Van Der Hoek M, et al. (2012) Efficacy and mechanisms of action of vitamin D in experimental polyarthritis. Immunol Cell Biol 90: 168–177.
- 17. Becklund BR, Severson KS, Vang SV, DeLuca HF (2010) UV radiation suppresses experimental autoimmune encephalomyelitis independent of vitamin D production. Proc Natl Acad Sci U S A 107: 6418–6423.
- 18. Biggs L, Yu C, Fedoric B, Lopez AF, Galli SJ, Grimbaleston MA (2010) Evidence that vitamin D(3) promotes mast cell-dependent reduction of chronic UVB-induced skin pathology in mice. J Exp Med 207: 455–463.
- 19. Hart PH, Grimbaldeston MA, Swift GJ, Jaksic A, Noonan FP, et al. (1998) Dermal mast cells determine susceptibility to ultraviolet B-induced systemic suppression of contact hypersensitivity responses in mice. J Exp Med 187: 2045–2053.
- 20. Gorman S, Tan JW, Yerkovich ST, Finlay-Jones JJ, Hart PH (2007) CD4+ T cells in lymph nodes of UVB-irradiated mice suppress immune responses to new antigens both in vitro and in vivo. J Invest Dermatol 127: 915–924.
- 21. Tuckey RC, Stevenson PM (1985) Purification and analysis of phospholipids in the inner mitochondrial membrane fraction of the bovine corpus luteum, and properties of cytochrome P-450scc incorporated into vesicles prepared from these phospholipids. Eur J Biochem 148: 379–384.
- 22. How KL, Hazewinkel HAW, Mol JA (1994) Dietary vitamin D dependence of cat and dog due to inadequate cutaneous synthesis of vitamin D. Gen Comp Endocrinol. 96: 12–18.
- 23. Gorman S, Judge MA, Hart PH (2010) Immune-modifying properties of topical vitamin D: focus on dendritic cells and T cells. J Steroid Biochem Mol Biol 121: 247–249.
- 24. Ng RL, Bisley JL, Gorman S, Norval M, Hart PH (2010) Ultraviolet irradiation of mice reduces the competency of bone marrow-derived CD11c+ cells via an indomethacin-inhibitable pathway. J Immunol 185: 7207–7215.
- 25. McGlade JP, Gorman S, Zosky GR, Larcombe AN, Sly PD, et al. (2007) Suppression of the asthmatic phenotype by UVB-induced, antigen-specific regulatory cells. Clin Exp Allergy 37: 1267–1276.
- 26. Gorman S, Tan DHW, Lambert MJM, Scott NM, Judge MA, et al. (2012) Vitamin D(3) deficiency enhances allergen-induced lymphocyte responses in a mouse model of allergic airway disease. Pediatric Allergy Immunol 23: 83–87.
- 27. Lehmann B, Sauter W, Knuschke P, Dressler S, Meurer M (2003) Demonstration of UVB-induced synthesis of 1,25-dihydroxyvitamin D3 (calcitriol) in human skin by microdialysis. Arch Dermatol Res 295: 24–28.
- 28. Ullrich SE (2005) Mechanisms underlying UV-induced immune suppression. Mut Res 571: 185–205.
- 29. Norval M (2006) The mechanisms and consequences of ultraviolet-induced immunosuppression. Prog Biophys Mol Biol 92: 108–118.
- 30. McGlade JP, Gorman S, Lenzo JC, Tan JW, Watanabe T (2007) Effect of both UVB irradiation and histamine receptor function on allergic responses to an inhaled antigen. J Immunol 178: 2794–2802.
- 31. Soontrapa K, Honda T, Sakata D, Yao C, Hirata T (2011) Prostaglandin E2-prostaglandin E receptor subtype 4 (EP4) signaling mediates UV irradiation-induced systemic immunosuppression. Proc Nat Acad Sci U S A 108: 6668–6673.
- 32. Paterson CR, Moody JP, Pennington CR (1997) Skin content of 7-dehydrocholesterol in patients with malabsorption. Nutrition 13: 771–773.
- 33. MacLaughlin J, Holick MF (1985) Aging decreases the capacity of human skin to produce vitamin D3. J Clin Invest 76: 1536–1538.
- 34. Spach KM, Hayes CE (2005) Vitamin D3 confers protection from autoimmune encephalomyelitis only in female mice. J Immunol 175: 4119–4126.
- 35. Miyauchi H, Horio T (1995) Ultraviolet B-induced local immunosuppression of contact hypersensitivity is modulated by ultraviolet irradiation and hapten application. J Invest Dermatol 104: 364–369.
- 36. Reeve VE, Allanson M, Domanski D, Painter N (2012) Gender differences in UV-induced inflammation and immunosuppression in mice reveal male unresponsiveness to UVA radiation. Photochem Photobiol Sci 11: 173–179.
- 37. Hauser SL, Weiner HL, Che M, Shapiro ME, Gilles F (1984) Prevention of experimental allergic encephalomyelitis (EAE) in the SJL/J mouse by whole body ultraviolet irradiation. J Immunol 132: 1276–1281.
- 38. Cantorna MT, Humpal-Winter J, DeLuca HF (1999) Dietary calcium is a major factor in 1,25-dihydroxycholecalciferol suppression of experimental autoimmune encephalomyelitis in mice. J Nutr 129: 1966–1971.
- 39. Song Y, Kato S, Fleet JC (2002) Vitamin D receptor (VDR) knockout mice reveal VDR-independent regulation of intestinal calcium absorption and ECaC2 and calbindin D9k mRNA. J Nutr 133: 370–380.
- 40. Ellison TI, Smith MK, Gilliam AC, MacDonald PN (2008) Inactivation of the vitamin D receptor enhances susceptibility of murine skin to UV-induced tumorigenesis. J Invest Dermatol 128: 2508–2517.
- 41. Zhang ZL, Ding XF, Tong J, Li BY (2011) Partial rescue of the phenotype in 1a-hydroxylase gene knockout mice by vitamin D3 injection. Endocr Res 36: 101–108.
- 42. Wittke A, Chang A, Froicu M, Harandi OF, Weaver V (2007) Vitamin D receptor expression by the lung micro-environment is required for maximal induction of lung inflammation. Arch Biochem Biophys 15: 306–313.
- 43. Matheu V, Back V, Mondoc E, Issazadeh-Navikas S (2003) Dual effects of vitamin D-induced alteration of TH1/TH2 cytokine expression: enhancing IgE production and decreasing airway eosinophilia and murine allergic airway disease. J Allergy Clin Immunol 112: 585–592.
- 44. Topilski I, Flaishon L, Naveh Y, Harmelin A, Levo Y, et al. (2004) The anti-inflammatory effects of 1,25-dihydroxyvitamin D3 on Th2 cells in vivo are due in part to the control of integrin-mediated T lymphocyte homing. Eur J Immunol 34: 1068–1076.
- 45. Taher YA, van Esch BCAM, Hofman GA, Henricks PAJ, van Oosterhout AJM (2008) 1a,25-Dihydroxyvitamin D3 potentitates the beneficial effects of allergen immunotherapy in a mouse model of allergic asthma: role for IL-10 and TGF-β. J Immunol 180: 5211–5221.